126 related articles for article (PubMed ID: 9576275)
1. Hydroxyurea for treatment of meningioma.
Cusimano MD
J Neurosurg; 1998 May; 88(5):938-9. PubMed ID: 9576275
[No Abstract] [Full Text] [Related]
2. Treatment of high risk or recurrent meningiomas with hydroxyurea.
Rosenthal MA; Ashley DL; Cher L
J Clin Neurosci; 2002 Mar; 9(2):156-8. PubMed ID: 11922703
[TBL] [Abstract][Full Text] [Related]
3. Stabilization of disease progression by hydroxyurea in patients with recurrent or unresectable meningioma.
Mason WP; Gentili F; Macdonald DR; Hariharan S; Cruz CR; Abrey LE
J Neurosurg; 2002 Aug; 97(2):341-6. PubMed ID: 12186462
[TBL] [Abstract][Full Text] [Related]
4. Hydroxyurea for treatment of unresectable meningiomas.
Schrell UM; Rittig MG; Koch U; Marschalek R; Anders M
Lancet; 1996 Sep; 348(9031):888-9. PubMed ID: 8826822
[No Abstract] [Full Text] [Related]
5. Meningioma of the optic nerve sheath: treatment with hydroxyurea.
Paus S; Klockgether T; Urbach H; Schlegel U
J Neurol Neurosurg Psychiatry; 2003 Sep; 74(9):1348-50. PubMed ID: 12933956
[No Abstract] [Full Text] [Related]
6. Giving another chance to mifepristone in pharmacotherapy for aggressive meningiomas-A likely synergism with hydroxyurea?
Elmaci İ; Altinoz MA; Sav A; Yazici Z; Ozpinar A
Curr Probl Cancer; 2016; 40(5-6):229-243. PubMed ID: 27320011
[No Abstract] [Full Text] [Related]
7. Spinal meningioma during hydroxyurea therapy. A paradoxycal case report.
Giordano F; Savarino A; Pagni CA
Neurol Sci; 2002 Sep; 23(3):127-9. PubMed ID: 12391498
[TBL] [Abstract][Full Text] [Related]
8. Hydroxyurea for treatment of unresectable and recurrent meningiomas. I. Inhibition of primary human meningioma cells in culture and in meningioma transplants by induction of the apoptotic pathway.
Schrell UM; Rittig MG; Anders M; Kiesewetter F; Marschalek R; Koch UH; Fahlbusch R
J Neurosurg; 1997 May; 86(5):845-52. PubMed ID: 9126901
[TBL] [Abstract][Full Text] [Related]
9. Hydroxyurea for treatment of unresectable and recurrent meningiomas. II. Decrease in the size of meningiomas in patients treated with hydroxyurea.
Schrell UM; Rittig MG; Anders M; Koch UH; Marschalek R; Kiesewetter F; Fahlbusch R
J Neurosurg; 1997 May; 86(5):840-4. PubMed ID: 9126900
[TBL] [Abstract][Full Text] [Related]
10. Hydroxyurea chemotherapy in the treatment of meningiomas.
Newton HB
Neurosurg Focus; 2007; 23(4):E11. PubMed ID: 17961035
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy: What is its role in meningioma?
Sherman WJ; Raizer JJ
Expert Rev Neurother; 2012 Oct; 12(10):1189-95; quiz 1196. PubMed ID: 23082735
[TBL] [Abstract][Full Text] [Related]
12. Hydroxyurea for recurrent surgery and radiation refractory meningioma: a retrospective case series.
Chamberlain MC; Johnston SK
J Neurooncol; 2011 Sep; 104(3):765-71. PubMed ID: 21318318
[TBL] [Abstract][Full Text] [Related]
13. Hydroxyurea with or without imatinib in the treatment of recurrent or progressive meningiomas: a randomized phase II trial by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO).
Mazza E; Brandes A; Zanon S; Eoli M; Lombardi G; Faedi M; Franceschi E; Reni M
Cancer Chemother Pharmacol; 2016 Jan; 77(1):115-20. PubMed ID: 26659583
[TBL] [Abstract][Full Text] [Related]
14. Prolonged oral hydroxyurea and concurrent 3d-conformal radiation in patients with progressive or recurrent meningioma: results of a pilot study.
Hahn BM; Schrell UM; Sauer R; Fahlbusch R; Ganslandt O; Grabenbauer GG
J Neurooncol; 2005 Sep; 74(2):157-65. PubMed ID: 16193387
[TBL] [Abstract][Full Text] [Related]
15. Hydroxyurea chemotherapy for unresectable or residual meningioma.
Newton HB; Slivka MA; Stevens C
J Neurooncol; 2000 Sep; 49(2):165-70. PubMed ID: 11206012
[TBL] [Abstract][Full Text] [Related]
16. Hydroxyurea chemotherapy for meningiomas: enlarged cohort with extended follow-up.
Newton HB; Scott SR; Volpi C
Br J Neurosurg; 2004 Oct; 18(5):495-9. PubMed ID: 15799152
[TBL] [Abstract][Full Text] [Related]
17. Phase II study of Gleevec® plus hydroxyurea (HU) in adults with progressive or recurrent meningioma.
Reardon DA; Norden AD; Desjardins A; Vredenburgh JJ; Herndon JE; Coan A; Sampson JH; Gururangan S; Peters KB; McLendon RE; Norfleet JA; Lipp ES; Drappatz J; Wen PY; Friedman HS
J Neurooncol; 2012 Jan; 106(2):409-15. PubMed ID: 21938530
[TBL] [Abstract][Full Text] [Related]
18. Non-resectable slow-growing meningiomas treated by hydroxyurea.
Loven D; Hardoff R; Sever ZB; Steinmetz AP; Gornish M; Rappaport ZH; Fenig E; Ram Z; Sulkes A
J Neurooncol; 2004; 67(1-2):221-6. PubMed ID: 15072471
[TBL] [Abstract][Full Text] [Related]
19. Phase II study of monthly pasireotide LAR (SOM230C) for recurrent or progressive meningioma.
Chamberlain MC
Neurology; 2015 Sep; 85(12):1090. PubMed ID: 26391415
[No Abstract] [Full Text] [Related]
20. Author response.
Wen PY; Norden AD
Neurology; 2015 Sep; 85(12):1090. PubMed ID: 26645061
[No Abstract] [Full Text] [Related]
[Next] [New Search]
